Replies to post #439813 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

oh, so 5.6%? I think we were guessing 8% prior

[meirluc]

Thank you Flipper for the information. I believe that excluding GBM patients with the Proneural phenotype and the IDH1 mutation bodes well for the results because it will increase the proportion of long living Treatment patients and will decrease the proportion of long living Control patients.